{"DataElement":{"publicId":"2998197","version":"1","preferredName":"Local Clinical Study Phase StudyPhaseCode","preferredDefinition":"Of or belonging to a restricted area or locality.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle._The stage of a clinical trial study.","longName":"2992871v1.0:2997970v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2992871","version":"1","preferredName":"Local Clinical Study Phase","preferredDefinition":"Of or belonging to a restricted area or locality.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","longName":"2992590v1.0:2223291v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2992590","version":"1","preferredName":"Local Clinical Study","preferredDefinition":"Of or belonging to a restricted area or locality.:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","longName":"C67263:C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local","conceptCode":"C67263","definition":"Of or belonging to a restricted area or locality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E143DD4-70B8-D31C-E040-BB89AD437865","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223291","version":"1","preferredName":"Phase","preferredDefinition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","longName":"C25257","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase","conceptCode":"C25257","definition":"A distinguishable part, a stage in a series of events or in a process of development, e.g. any of the varying aspects or stages in course of a disease; a fraction of a cycle.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B0359-D8F5-231D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E145BA9-90EE-643C-E040-BB89AD435A44","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"8/9/12 - Released as part of caAERS v2.0 model cleanup.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2997970","version":"1","preferredName":"StudyPhaseCode","preferredDefinition":"The stage of a clinical trial study.","longName":"2997970v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Phase_0","valueDescription":"Phase 0 Trial","ValueMeaning":{"publicId":"2698170","version":"1","preferredName":"Phase 0 Trial","longName":"2698170","preferredDefinition":"A clinical trial that uses an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited.  ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase 0 Trial","conceptCode":"C54721","definition":"A clinical trial that uses an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FEC515A-6612-1907-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9CBB-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_I/II","valueDescription":"Phase I/II Trial","ValueMeaning":{"publicId":"2578680","version":"1","preferredName":"Phase I/II Trial","longName":"2578680","preferredDefinition":"A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase I/II Trial","conceptCode":"C15693","definition":"A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9CCD-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_II","valueDescription":"Phase II Trial","ValueMeaning":{"publicId":"2578681","version":"1","preferredName":"Phase II Trial","longName":"2578681","preferredDefinition":"A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase II Trial","conceptCode":"C15601","definition":"A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0066-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"TAYLORT","dateModified":"2020-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9CDF-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_II/III","valueDescription":"Phase II/III Trial","ValueMeaning":{"publicId":"2579213","version":"1","preferredName":"Phase II/III Trial","longName":"2579213","preferredDefinition":"A trial to study response to a new treatment and the effectiveness of the treatment compared with the standard treatment regimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase II/III Trial","conceptCode":"C15694","definition":"A type of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-027A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9CF1-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_III","valueDescription":"Phase III Trial","ValueMeaning":{"publicId":"2578682","version":"1","preferredName":"Phase III Trial","longName":"2578682","preferredDefinition":"A study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into phase III only after a treatment seems to work in phases I and II. Phase III trials may include hundreds of people.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase III Trial","conceptCode":"C15602","definition":"A clinical research protocol designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0067-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9D03-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_I","valueDescription":"Phase I Trial","ValueMeaning":{"publicId":"2578679","version":"1","preferredName":"Phase I Trial","longName":"2578679","preferredDefinition":"A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase I Trial","conceptCode":"C15600","definition":"A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0064-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"TAYLORT","dateModified":"2020-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9D15-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Phase_IV","valueDescription":"Phase IV Trial","ValueMeaning":{"publicId":"2578683","version":"1","preferredName":"Phase IV Trial","longName":"2578683","preferredDefinition":"Generally, a Phase IV trial is a randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase IV Trial","conceptCode":"C15603","definition":"A randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0068-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9D27-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"},{"value":"Pilot","valueDescription":"Pilot Study","ValueMeaning":{"publicId":"2959654","version":"1","preferredName":"Pilot Study","longName":"2959654","preferredDefinition":"The initial study examining a new method or treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilot Study","conceptCode":"C15303","definition":"The initial study examining a new method or treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB5771-AF30-2FA1-E040-BB89AD4307F2","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7E1B46F5-9D31-8C78-E040-BB89AD435B99","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"ONEDATA","dateModified":"2010-01-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E1B46F5-9CA1-8C78-E040-BB89AD435B99","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"CHILLIJ","dateModified":"2012-08-13","changeDescription":"8/13/12 - Released as part of caAERS v2.0 model cleanup; VD associated with CS/CSI.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2747429","version":"2","longName":"caAERS","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000413","version":"1","longName":"gov.nih.nci.cabig.caaers.domain","context":"NCIP"}]}],"AlternateNames":[{"name":"gov.nih.nci.cabig.caaers.domain.LocalStudy.phaseCode","type":"UML Qualified Attr","context":"NCIP"},{"name":"LocalStudy:phaseCode","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Local Clinical Study Phase StudyPhaseCode does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Local Clinical Study Phase StudyPhaseCode does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E1B8BB6-2B8C-5EE9-E040-BB89AD43730B","latestVersionIndicator":"Yes","beginDate":"2010-01-26","endDate":null,"createdBy":"UMLLOADER_CAAERSPRD","dateCreated":"2010-01-26","modifiedBy":"CHILLIJ","dateModified":"2012-08-13","changeDescription":"8/13/12 - Released as part of caAERS v2.0 model cleanup.  jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}